J. Refugia, Emily Roebuck, P. Thakker, Ashok Hemal, Matvey Tsivian
{"title":"EARLY CLINICAL EXPERIENCE WITH SEQUENTIAL INTRAVESICAL GEMCITABINE-DOCETAXEL FOR TREATMENT-NAIVE HIGH RISK NON-MUSCLE INVASIVE BLADDER CANCER","authors":"J. Refugia, Emily Roebuck, P. Thakker, Ashok Hemal, Matvey Tsivian","doi":"10.1016/j.urolonc.2024.01.153","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":506909,"journal":{"name":"Urologic Oncology: Seminars and Original Investigations","volume":"74 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urologic Oncology: Seminars and Original Investigations","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.urolonc.2024.01.153","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}